NGVT on NYSE
Ingevity Corp
American chemicals and allied products company based in North Charleston2
In its 2026 annual report the company says: “Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable.”5 Its shares trade on NYSE under the symbol NGVT.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with BALCHEM CORP, Innospec or Ecovyst Inc., or pick any stock.
- TickerNGVT on NYSE2
- IndustryChemicals & Allied Products2
- HeadquartersNorth Charleston, United States2
- Incorporated inDE3
- Business address4920 O'Hear Avenue, Suite 400, North Charleston, Sc 294053
- Filer categoryLarge accelerated filer3
- Legal formCorporation2
- LEI5493009UTFC4B5IMGF872
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 57190842
See how the biggest companies compare on our leaderboards
Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. Through a diverse team of talented and experienced people, we develop, manufacture, and bring to market solutions that are largely renewably sourced and help customers solve complex problems while making the world more sustainable. Our products are used in a variety of demanding applications, including automotive gasoline vapor emissions control systems, food, water and chemical filtration, asphalt paving, agrochemical dispersants, bioplastics, coatings, elastomers, and paint for road markings. We operate in three reportable segments: Performance Materials, Performance Chemicals and Advanced Polymer Technologies.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
39.5%Gross margin6
35.9%Operating margin6
-14.3%Net margin6
-2.7%Revenue growth, 20256
-562.6%Return on equity6
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Performance Materials brought in 52% of the revenue Ingevity Corp broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Performance Materials | $586.0M | $609.6M | $606.9M |
| Performance Chemicals | $425.5M | $401.9M | $400.5M |
| Advanced Polymer Technologies | $204.0M | $188.6M | $160.2M |
Regions
North America brought in 35% of the revenue Ingevity Corp broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| North America | $672.7M | $651.5M | $665.1M |
| United States | $602.3M | $571.5M | $585.0M |
| Asia Pacific | $323.3M | $325.0M | $298.5M |
| EMEA | $179.9M | $172.4M | $158.9M |
| China | $189.2M | $175.6M | $153.1M |
| South America | $39.6M | $51.2M | $45.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue60¢$706.1M
- Research and development2¢$28.4M
- Selling, general and admin15¢$171.2M
- Other costs15¢$175.4M
- Interest7¢$78.3M
- Income tax1¢$8.2M
Out of $1.2B in revenue.6 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Share buybacks17¢$56.3M
- Kept or used elsewhere83¢$274.9M
Out of $331.2M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $1.2B | $1.2B | $1.2B |
| Cost of sales | $706.1M | $735.3M | $770.5M |
| Gross profit | $461.5M | $464.8M | $445.0M |
| Selling, general, and administrative expenses | $171.2M | $157.8M | $161.8M |
| Research and technical expenses | $28.4M | $24.5M | $25.4M |
| Restructuring and other (income) charges, net | $12.8M | $18.1M | $53.4M |
| Goodwill impairment charge | $183.8M | $306.6M | $0 |
| Long lived asset impairment charge | $109.3M | $0 | $0 |
| Acquisition-related costs | $0 | $300.0K | $3.6M |
| Other (income) expense, net | $25.0M | $7.9M | -$16.2M |
| Interest expense | $78.3M | $97.8M | $93.3M |
| Interest income | -$5.2M | -$7.7M | -$6.3M |
| Income (loss) from continuing operations before income taxes | -$142.1M | -$140.5M | $130.0M |
| Provision (benefit) for income taxes on continuing operations | $8.2M | -$19.1M | $24.2M |
| Net income (loss) from continuing operations | -$150.3M | -$121.4M | $105.8M |
| Income (loss) from discontinued operations, net of income taxes | -$16.8M | -$308.9M | -$111.2M |
| Net income (loss) | -$167.1M | -$430.3M | -$5.4M |
| Basic earnings (loss) per share from continuing operations (usd per share) | -$4 | -$3 | $3 |
| Basic earnings (loss) per share from continuing operations (usd per share) | -$0 | -$9 | -$3 |
| Basic earnings (loss) per share (usd per share) | -$4.61 | -$11.85 | -$0.15 |
| Diluted earnings (loss) per share from continuing operations (usd per share) | -$4 | -$3 | $3 |
| Diluted earnings (loss) per share from discontinued operations (usd per share) | -$0 | -$9 | -$3 |
| Diluted earnings (loss) per share (usd per share) | -$4.61 | -$11.85 | -$0.15 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $78.1M | $68.0M | $95.9M | |
| Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024 | $127.2M | $131.7M | ||
| Inventories, net | $186.0M | $195.9M | ||
| Prepaid and other current assets | $47.0M | $51.1M | ||
| Current assets of discontinued operations | $15.9M | $46.5M | ||
| Current assets | $454.2M | $493.2M | ||
| Property, plant, and equipment, net | $608.1M | $642.9M | ||
| Operating lease assets, net | $29.5M | $44.7M | ||
| Goodwill | $4.3M | $175.2M | ||
| Other intangibles, net | $176.1M | $278.8M | ||
| Deferred income taxes | $117.0M | $117.9M | ||
| Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024 | $84.4M | $81.6M | ||
| Strategic investments | $83.1M | $87.3M | ||
| Other assets | $74.9M | $79.2M | ||
| Noncurrent assets of discontinued operations | $19.5M | $21.8M | ||
| Total Assets | $1.7B | $2.0B | ||
| Accounts payable | $92.0M | $94.5M | ||
| Accrued expenses | $148.0M | $58.1M | ||
| Accrued payroll and employee benefits | $34.6M | $27.3M | ||
| Current operating lease liabilities | $11.8M | $14.4M | ||
| Notes payable and current maturities of long-term debt | $47.1M | $61.3M | ||
| Income taxes payable | $4.7M | $5.6M | ||
| Current liabilities of discontinued operations | $3.1M | $2.9M | ||
| Current liabilities | $341.3M | $264.1M | ||
| Long-term debt including finance lease obligations | $1.2B | $1.3B | ||
| Noncurrent operating lease liabilities | $22.4M | $33.6M | ||
| Deferred income taxes | $55.1M | $56.2M | ||
| Other liabilities | $40.5M | $130.6M | ||
| Noncurrent liabilities of discontinued operations | $700.0K | $3.2M | ||
| Total Liabilities | $1.6B | $1.8B | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024) | $0 | $0 | ||
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively) | $400.0K | $400.0K | ||
| Additional paid-in capital | $195.7M | $176.8M | ||
| Retained earnings | $404.9M | $572.0M | ||
| Accumulated other comprehensive income (loss) | $500.0K | -$41.4M | ||
| Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024) | -$571.8M | -$512.6M | ||
| Total Equity | $29.7M | $195.2M | $631.4M | $698.3M |
| Total Liabilities and Equity | $1.7B | $2.0B | ||
| Allowance for accounts receivable | $1.5M | $600.0K | ||
| Held-to-maturity, allowance for credit loss | $200.0K | $200.0K | ||
| Preferred stock, par value (usd per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 43.9M shares | 43.6M shares | ||
| Common stock shares outstanding (shares) | 35.5M shares | 36.4M shares | ||
| Treasury stock (shares) | 8.4M shares | 7.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $78.1M | $68.0M | $95.9M | |
| Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024 | $127.2M | $131.7M | ||
| Inventories, net | $186.0M | $195.9M | ||
| Prepaid and other current assets | $47.0M | $51.1M | ||
| Current assets of discontinued operations | $15.9M | $46.5M | ||
| Current assets | $454.2M | $493.2M | ||
| Property, plant, and equipment, net | $608.1M | $642.9M | ||
| Operating lease assets, net | $29.5M | $44.7M | ||
| Goodwill | $4.3M | $175.2M | ||
| Other intangibles, net | $176.1M | $278.8M | ||
| Deferred income taxes | $117.0M | $117.9M | ||
| Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024 | $84.4M | $81.6M | ||
| Strategic investments | $83.1M | $87.3M | ||
| Other assets | $74.9M | $79.2M | ||
| Noncurrent assets of discontinued operations | $19.5M | $21.8M | ||
| Total Assets | $1.7B | $2.0B | ||
| Accounts payable | $92.0M | $94.5M | ||
| Accrued expenses | $148.0M | $58.1M | ||
| Accrued payroll and employee benefits | $34.6M | $27.3M | ||
| Current operating lease liabilities | $11.8M | $14.4M | ||
| Notes payable and current maturities of long-term debt | $47.1M | $61.3M | ||
| Income taxes payable | $4.7M | $5.6M | ||
| Current liabilities of discontinued operations | $3.1M | $2.9M | ||
| Current liabilities | $341.3M | $264.1M | ||
| Long-term debt including finance lease obligations | $1.2B | $1.3B | ||
| Noncurrent operating lease liabilities | $22.4M | $33.6M | ||
| Deferred income taxes | $55.1M | $56.2M | ||
| Other liabilities | $40.5M | $130.6M | ||
| Noncurrent liabilities of discontinued operations | $700.0K | $3.2M | ||
| Total Liabilities | $1.6B | $1.8B | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024) | $0 | $0 | ||
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively) | $400.0K | $400.0K | ||
| Additional paid-in capital | $195.7M | $176.8M | ||
| Retained earnings | $404.9M | $572.0M | ||
| Accumulated other comprehensive income (loss) | $500.0K | -$41.4M | ||
| Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024) | -$571.8M | -$512.6M | ||
| Total Equity | $29.7M | $195.2M | $631.4M | $698.3M |
| Total Liabilities and Equity | $1.7B | $2.0B | ||
| Allowance for accounts receivable | $1.5M | $600.0K | ||
| Held-to-maturity, allowance for credit loss | $200.0K | $200.0K | ||
| Preferred stock, par value (usd per share) | $0.01 | $0.01 | ||
| Preferred stock, shares authorized (shares) | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued (shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (shares) | 0 shares | 0 shares | ||
| Common stock, par value (usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (shares) | 300.0M shares | 300.0M shares | ||
| Common stock, shares issued (shares) | 43.9M shares | 43.6M shares | ||
| Common stock shares outstanding (shares) | 35.5M shares | 36.4M shares | ||
| Treasury stock (shares) | 8.4M shares | 7.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | -$167.1M | -$430.3M | -$5.4M |
| Depreciation and amortization | $106.4M | $108.3M | $122.8M |
| Non cash operating lease costs | $14.7M | $19.1M | $18.6M |
| Deferred income taxes | -$4.7M | -$121.4M | -$44.7M |
| Disposal/impairment of assets | $3.2M | $1.3M | $4.3M |
| Restructuring and other (income) charges, net | $55.7M | $186.2M | $170.2M |
| CTO resales | $0 | $52.7M | $22.0M |
| LIFO liquidation | -$6.8M | -$5.8M | -$28.5M |
| Share-based compensation | $18.3M | $11.9M | $10.6M |
| (Gain) loss on strategic investment | $26.2M | $11.4M | -$19.3M |
| Pension and other postretirement benefit costs | $1.2M | $1.5M | $1.6M |
| Goodwill impairment charge | $183.8M | $349.1M | $0 |
| Impairment, long-lived asset, held-for-use | $109.3M | $0 | $0 |
| Other non-cash items | $7.6M | $17.0M | $36.2M |
| Accounts receivable, net | $12.2M | $38.2M | $42.7M |
| Inventories, net | $40.2M | $73.3M | $25.8M |
| Prepaid and other current assets | $1.3M | $7.7M | -$28.6M |
| Planned major maintenance outage | -$6.5M | -$6.5M | -$12.8M |
| Accounts payable | -$2.6M | -$63.4M | -$14.6M |
| Accrued expenses | -$14.1M | -$1.0M | -$7.7M |
| Accrued payroll and employee benefits | $6.9M | $8.0M | -$33.5M |
| Income taxes | -$1.2M | -$13.8M | $6.4M |
| Operating leases | -$19.5M | -$21.7M | -$22.5M |
| Restructuring and other spending | -$46.1M | -$59.3M | -$44.0M |
| CTO resales | $6.2M | -$46.1M | -$10.6M |
| Changes in all other operating assets and liabilities, net | $6.6M | $12.2M | $16.1M |
| Net cash provided by (used in) operating activities | $331.2M | $128.6M | $205.1M |
| Capital expenditures | -$57.7M | -$77.6M | -$109.8M |
| Proceeds from disposition of assets | $3.6M | $0 | |
| Sale (purchase) of strategic investments, net | -$16.4M | -$300.0K | $29.1M |
| Restricted investment | $13.0M | $0 | $7.0M |
| Other investing activities, net | $0 | -$1.6M | -$3.6M |
| Net cash provided by (used in) investing activities | -$57.5M | -$79.5M | -$77.3M |
| Proceeds from revolving credit facility and other borrowings | $291.3M | $404.5M | $376.3M |
| Payments on revolving credit facility and other borrowings | -$483.6M | -$470.6M | -$382.9M |
| Debt issuance costs | $0 | $0 | -$400.0K |
| Financing lease obligations, net | -$1.3M | -$1.0M | -$700.0K |
| Tax payments related to withholdings on vested equity awards | -$3.7M | -$3.1M | -$4.8M |
| Proceeds and withholdings from share-based compensation plans, net | $1.4M | $0 | $4.7M |
| Repurchases of common stock under publicly announced plan | -$56.3M | $0 | -$92.1M |
| Net cash provided by (used in) financing activities | -$252.2M | -$70.2M | -$99.9M |
| Increase (decrease) in cash, cash equivalents, and restricted cash | $21.5M | -$21.1M | $27.9M |
| Effect of exchange rate changes on cash | $4.5M | -$4.2M | -$300.0K |
| Change in cash, cash equivalents, and restricted cash | $26.0M | -$25.3M | $27.6M |
| Cash paid for interest, net of capitalized interest | $70.4M | $85.4M | $82.7M |
| Cash paid for income taxes, net of refunds | $10.9M | $26.9M | $29.7M |
| Purchases of property, plant, and equipment in accounts payable | $1.7M | $2.4M | $2.8M |
| Leased assets obtained in exchange for new finance lease liabilities | $0 | $0 | $200.0K |
| Leased assets obtained in exchange for new operating lease liabilities | $1.8M | $6.0M | $29.1M |
No quarter-by-quarter statement was filed.
Corporate structure
Ingevity Corp sits at the top of its group. 20 entities, 10 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Ingevity Corp
- Wellington Management Company Filed SCHEDULE 13G/A on Ingevity Corp, latest May 15, 2026 (3 filings since Feb 4, 2022)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Ingevity Corp, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Ingevity Corp, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Ingevity Corp, latest Mar 27, 2026 (7 filings since Feb 10, 2022)
- VICTORY CAPITAL MANAGEMENT INC Filed SCHEDULE 13G/A on Ingevity Corp, latest Oct 24, 2025 (2 filings since Feb 7, 2024)
- BlackRock Filed SCHEDULE 13G/A on Ingevity Corp, latest Apr 30, 2025 (6 filings since Jan 26, 2022)
- INCLUSIVE CAPITAL PARTNERS, L.P. Filed SC 13D/A on Ingevity Corp, latest Feb 28, 2024 (4 filings since Apr 7, 2022)
- Boston Partners Filed SC 13G/A on Ingevity Corp, latest Feb 14, 2022
- Ingevity Corp North Charleston, South Carolina, United States
- Ingevity Arkansas, LLC Subsidiary · Delaware, United States
- Ingevity Australia Pty Ltd Subsidiary · Australia
- Ingevity Georgia, LLC Subsidiary · Delaware, United States
- Ingevity Holding Co., Ltd. Subsidiary · China
- Ingevity Holdings SRL Subsidiary · Belgium
- Ingevity Hong Kong Limited Subsidiary · Hong Kong
- Ingevity India Private Limited Subsidiary · India
- Ingevity Japan, GK Subsidiary · Japan
- Ingevity Mexico, S.A. de C.V. Subsidiary · Mexico
- Ingevity Performance Materials (Changshu) Co., Ltd. Subsidiary · China
- Ingevity Performance Materials (Zhuhai) Co., Ltd. Subsidiary · China
- Ingevity Quimica Ltda. Subsidiary · Brazil
- Ingevity Services, Inc. Subsidiary · Delaware, United States
- Ingevity South Carolina, LLC Subsidiary · Delaware, United States
- Ingevity Trade Receivables, LLC Subsidiary · Delaware, United States
- Ingevity UK Ltd Subsidiary · United Kingdom
- Ingevity Virginia Corporation Subsidiary · Virginia, United States
- Ozark Logistics, LLC Subsidiary · Alabama, United States
- Ozark Materials, LLC Subsidiary · Alabama, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Ingevity Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $1.6B6 Dec 31, 2025 | $1.6B6 Dec 31, 2024 | +0.2% |
| Accumulated depreciation | $967.2M6 Dec 31, 2025 | $929.4M6 Dec 31, 2024 | +4.1% |
| Property and equipment, net | $608.1M6 Dec 31, 2025 | $642.9M6 Dec 31, 2024 | −5.4% |
| Finance-lease assets | $37.0M6 Dec 31, 2025 | $50.2M6 Dec 31, 2024 | −26.3% |
| Operating-lease assets (leased space) | $29.5M6 Dec 31, 2025 | $44.7M6 Dec 31, 2024 | −34.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $78.1M6 Dec 31, 2025 | $68.0M6 Dec 31, 2024 | +14.9% |
| Debt securities held to maturity | $50.6M6 Dec 31, 2025 | $63.6M6 Dec 31, 2024 | −20.4% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $4.3M6 Dec 31, 2025 | $175.2M6 Dec 31, 2024 | −97.5% |
| Finite-lived intangibles, gross | $345.9M6 Dec 31, 2025 | $445.0M6 Dec 31, 2024 | −22.3% |
| Accumulated amortization | $169.8M6 Dec 31, 2025 | $166.2M6 Dec 31, 2024 | +2.2% |
| Finite-lived intangibles, net | $176.1M6 Dec 31, 2025 | $278.8M6 Dec 31, 2024 | −36.8% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $186.0M6 Dec 31, 2025 | $195.9M6 Dec 31, 2024 | −5.1% |
| Raw materials | $45.7M6 Dec 31, 2025 | $49.2M6 Dec 31, 2024 | −7.1% |
Properties, in its own words
We are headquartered in North Charleston, South Carolina and operate manufacturing facilities in the U.S., United Kingdom, and the People's Republic of China and have business offices and warehouse and distribution facilities globally. The following locations represent the principal properties of Ingevity. We believe these facilities are adequate and suitable for our current operations, and that the production capacity of our facilities is sufficient to meet current demand. In the case of the properties identified as "Leased," we nevertheless own the manufacturing facilities and equipment.
Location · Own / Lease · Functional Use
The rest of Item 2
North Charleston, South Carolina · Own / Lease (1) · Corporate Headquarters;Application Labs;Performance Chemicals: Manufacturing
Covington, Virginia · Lease · Performance Materials: Manufacturing
Waynesboro, Georgia · Own (2) · Performance Materials: Manufacturing
Shanghai, People's Republic of China · Lease · Regional Headquarters; Application Lab
Wickliffe, Kentucky · Own (3) · Performance Materials: Manufacturing
Changshu, People's Republic of China · Lease · Performance Materials: Manufacturing
Warrington, United Kingdom · Lease · Advanced Polymer Technologies: Manufacturing, Application Lab
Zhuhai, People's Republic of China · Lease · Performance Materials: Manufacturing, Application Lab
Greenville, Alabama · Lease · Performance Chemicals: Manufacturing
Dayton, Nevada · Own · Performance Chemicals: Manufacturing
Childress, Texas · Own (4) · Performance Chemicals: Manufacturing
Marion, Indiana · Own · Performance Chemicals: Manufacturing
________________________
(1) Portions of the manufacturing operations are on leased land and our corporate headquarters building is leased.
(2) Certain manufacturing assets are subject to a finance lease with the Development Authority of Burke County (the county in which Waynesboro, Georgia is located).
(3) Certain manufacturing assets are subject to a finance lease.
(4) Portions of the manufacturing operations are on leased land.
Item 2 of the 10-K filed Feb 26, 2026.5
Leadership
Who has led Ingevity Corp, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
20202025
- Chief executive officerLuis M. Fernandez Oct 4, 2024 to Oct 4, 202414
- Chief executive officerJohn C. Fortson Mar 2, 2021 to Mar 1, 202415
- Chief executive officerRichard B. Kelson Mar 3, 2020 to Apr 28, 202016
- PresidentLuis M. Fernandez Oct 4, 2024 to Oct 4, 202414
- PresidentJohn C. Fortson Mar 2, 2021 to Mar 1, 202415
- PresidentRichard B. Kelson Mar 3, 2020 to Apr 28, 202016
- Chief financial officerPhillip John Platt Jul 28, 2026 to now17
- Chief financial officerMary Dean Hall Apr 19, 2021 to Jul 28, 202618
- Chief financial officerJohn C. Fortson Apr 25, 2016 to Mar 2, 202119
Board members and other officers (29)
- VP, Chief Accounting OfficerRyan Joseph Cotterman Jun 24, 2026 to now20
- SVP and Pres, APTMichael N. Shukov Mar 20, 2025 to now21
- SVP and Pres, Perf MaterialsRuth Castillo Nov 25, 2025 to now22
- SVP, OperationsClarence Reid Clontz Jr. Dec 18, 2025 to now23
- VP, CHRO, Dep Gen Coun & CCORyan C. Fisher Apr 8, 2024 to now24
- SVP, Chief HR OfficerTerrence M. Dyer Aug 13, 2024 to now25
- SVP, Perf Chem and Pres, EPSteven Paul Hulme Jan 10, 2022 to now26
- Chief Growth & Innov OfficerErik Spencer Ripple May 6, 2022 to Mar 1, 202327
- SVP, Chief HR OfficerChristine Stunyo Jun 27, 2022 to Mar 1, 202428
- EVP, Gen. Counsel & SecretaryStacy Cozad Feb 2, 2021 to Mar 1, 202429
- CAO & Corporate ControllerPhillip John Platt May 16, 2016 to now30
- EVP, President Perf MaterialsStuart Edward Woodcock Jr. May 16, 2016 to now31
- Board memberFrancis David Segal May 5, 2025 to now32
- Board memberJ. Kevin Willis Dec 19, 2024 to now33
- Board memberBruce D. Hoechner Feb 21, 2023 to now34
- Board memberBenjamin G. Wright Jul 27, 2022 to now35
- Board memberWilliam J. Slocum Jul 27, 2022 to Sep 29, 202336
- Board memberJohn C. Fortson Mar 2, 2021 to Mar 1, 202415
- Board memberDiane H. Gulyas Feb 26, 2019 to now37
- Board memberKaren G. Narwold Feb 26, 2019 to now38
- Board memberSteven C. Voorhees Apr 25, 2016 to May 16, 201639
- Board memberWard H. Dickson Apr 25, 2016 to May 16, 201640
- Board memberJean S. Blackwell May 2, 2016 to now41
- Board memberDaniel F. Sansone May 16, 2016 to now42
- Board memberFrederick J. Lynch May 16, 2016 to now43
- Board memberJ. Michael Fitzpatrick May 16, 2016 to May 2, 202244
- Board memberLuis M. Fernandez May 16, 2016 to now45
- Board memberRichard B. Kelson May 16, 2016 to Apr 28, 202046
- General counselKatherine Pryor Burgeson Apr 25, 2016 to Mar 6, 202047
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Ingevity Arkansas, LLC Delaware, United States of America4
- Ingevity Australia Pty Ltd Australia4
- Ingevity Corporation Delaware, United States of America4
- Ingevity Georgia, LLC Delaware, United States of America4
- Ingevity Holding Co., Ltd. China4
- Ingevity Holdings SRL Belgium4
- Ingevity Hong Kong Limited Hong Kong4
- Ingevity India Private Limited India4
- Ingevity Japan, GK Japan4
- Ingevity Mexico, S.A. de C.V. Mexico4
- Ingevity Performance Materials (Changshu) Co., Ltd. China4
- Ingevity Performance Materials (Zhuhai) Co., Ltd. China4
- Ingevity Quimica Ltda. Brazil4
- Ingevity Services, Inc. Delaware, United States of America4
- Ingevity South Carolina, LLC Delaware, United States of America4
- Ingevity Trade Receivables, LLC Delaware, United States of America4
- Ingevity UK Ltd United Kingdom4
- Ingevity Virginia Corporation Virginia, United States of America4
- Ozark Logistics, LLC Alabama, United States of America4
- Ozark Materials, LLC Alabama, United States of America4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Jul 29, 20268-K Results of operations48
- Jun 24, 20268-K Executive or director change49
- May 6, 20268-K Results of operations50
- May 4, 20268-K Executive or director change; Shareholder vote51
- Apr 15, 20268-K Regulation FD disclosure52
- Mar 30, 20268-K Entered a material agreement; New debt or obligation53
- Feb 25, 20268-K Results of operations; Regulation FD disclosure54
- Feb 23, 20268-K Executive or director change55
- Jan 5, 20268-K Entered a material agreement; Completed an acquisition or sale; Regulation FD disclosure56
- Dec 8, 20258-K Regulation FD disclosure57
- Dec 8, 20258-K Executive or director change; Regulation FD disclosure58
- Dec 1, 20258-K Regulation FD disclosure59
- Oct 4, 2024New chief executive Luis M. Fernandez becomes CEO14
- Mar 2, 2021New chief executive John C. Fortson becomes CEO15
- Mar 3, 2020New chief executive Richard B. Kelson becomes CEO16
- Mar 27, 2015Founded Ingevity Corp is founded2
Calendar
Coming up
- Nov 4, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.31 a share, on Nov 5, 2025.60
When it reported results
- Jul 29, 2026Reported quarterly or annual results48
- May 6, 2026Reported quarterly or annual results50
- Feb 25, 2026Reported quarterly or annual results54
- Nov 5, 2025Reported quarterly or annual results61
- Aug 4, 2025Reported quarterly or annual results62
- May 5, 2025Reported quarterly or annual results63
- Feb 18, 2025Reported quarterly or annual results64
- Jan 16, 2025Reported quarterly or annual results65
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
357 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 210 insider forms, 25 large holders, 48 other. The latest 20:
- Oct 2, 20264 EDGAR
- Oct 2, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 14, 20264 EDGAR
- Aug 12, 2026144 EDGAR
- Aug 11, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 3, 2026144 EDGAR
- Jul 30, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jul 28, 20264 EDGAR
- Jul 8, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jun 24, 20264 EDGAR
- Jun 24, 20263 EDGAR
- Jun 24, 20268-K EDGAR
- Jun 1, 20264 EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 7, 202610-Q EDGAR
The 357 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
13 open-market trades by officers, directors and large owners since October 2021: 0 buys and 13 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Li David HPresident & CEO | Sale | 92 | $74.71 | $6.9K | Form 4 |
| Aug 17, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.83 | $379.1K | Form 4 |
| Aug 14, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.73 | $378.6K | Form 4 |
| Aug 13, 2026 | Li David HPresident & CEO | Sale | 5,000 | $75.73 | $378.6K | Form 4 |
| Aug 12, 2026 | Li David HPresident & CEO | Sale | 5,000 | $76.62 | $383.1K | Form 4 |
| Aug 3, 2026 | Fisher Ryan C.SVP, Gen. Counsel & Secretary | Sale | 2,709 | $73.72 | $199.7K | Form 4 |
| May 28, 2026 | DYER TERRANCE MSVP, Chief HR Officer | Sale | 496 | $68.49 | $34.0K | Form 4 |
| Mar 7, 2023 | White Richard Allen JRSVP and Pres, Perf Chemicals | Sale | 1,439 | $81.00 | $116.6K | Form 4 |
| Mar 2, 2023 | WOODCOCK STUART EDWARD JR.EVP, President Perf Materials | Sale | 4,968 | $82.14 | $408.1K | Form 4 |
| Mar 2, 2023 | PLATT PHILLIP JOHNSVP, Chief Financial Officer | Sale | 8,847 | $81.71 | $722.9K | Form 4 |
| Dec 2, 2022 | Ripple Erik SpencerChief Growth and Innovation Of | Sale | 856 | $77.84 | $66.6K | Form 4 |
| Dec 1, 2022 | White Richard Allen JRSVP and Pres, Perf Chemicals | Sale | 1,639 | $77.97 | $127.8K | Form 4 |
| Nov 8, 2021 | Smith Michael P.EVP, President Perf Chemicals | Sale | 7,878 | $80.81 | $636.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Wellington Management CompanySCHEDULE 13G/A, 3 filings Feb 4, 2022 to May 15, 202666
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202667
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202668
- VANGUARD GROUP INCSCHEDULE 13G/A, 7 filings Feb 10, 2022 to Mar 27, 202669
- VICTORY CAPITAL MANAGEMENT INCSCHEDULE 13G/A, 2 filings Feb 7, 2024 to Oct 24, 202570
- BlackRockSCHEDULE 13G/A, 6 filings Jan 26, 2022 to Apr 30, 202571
- INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D/A, 4 filings Apr 7, 2022 to Feb 28, 202472
- Boston PartnersSC 13G/A, 1 filing Feb 14, 202273
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 5,364,204 | $400.5M | 0.0% | +66,489 |
| Vanguard Portfolio Management LLC | 2,376,803 | $177.5M | 0.0% | +200,072 |
| Vanguard Capital Management LLC | 1,571,127 | $117.3M | 0.0% | −10,744 |
| State Street Corp | 1,497,321 | $111.8M | 0.0% | +38,086 |
| American Century Companies Inc | 1,270,958 | $94.9M | 0.0% | −161,608 |
| Wellington Management Group Llp | 1,075,514 | $80.3M | 0.0% | −418,778 |
| Segall Bryant & Hamill, LLC | 1,054,605 | $78.7M | 0.9% | −54,443 |
| Millennium Management LLC | 992,049 | $74.1M | 0.1% | −163,323 |
| Brown Advisory Inc | 974,107 | $72.7M | 0.1% | −17,909 |
| Royce & Associates LP | 940,417 | $70.2M | 0.6% | +56,890 |
| Geode Capital Management, LLC | 919,109 | $68.6M | 0.0% | +31,998 |
| Simcoe Capital Management, LLC | 894,072 | $66.8M | 13.0% | −87,943 |
| Dimensional Fund Advisors LP | 787,776 | $58.8M | 0.0% | −10,933 |
| Principal Financial Group Inc | 761,985 | $56.9M | 0.0% | +83,948 |
| Harvey Partners, LLC | 734,307 | $54.8M | 3.8% | −9,193 |
| Victory Capital Management Inc | 680,912 | $50.8M | 0.0% | −60,252 |
| Goldman Sachs Group Inc | 632,506 | $47.2M | 0.0% | +58,129 |
| Maple Rock Capital Partners Inc. | 603,303 | $45.0M | 0.9% | No change |
| Charles Schwab Investment Management Inc | 541,400 | $40.4M | 0.0% | −66,852 |
| Vision One Management Partners, LP | 535,082 | $40.0M | 14.4% | +16,981 |
| Northern Trust Corp | 407,927 | $30.5M | 0.0% | +14,427 |
| Boston Partners | 389,683 | $29.1M | 0.0% | +9,684 |
| Rice Hall James & Associates, LLC | 351,203 | $26.2M | 1.3% | +6,065 |
| Invesco Ltd. | 330,421 | $24.7M | 0.0% | +39,729 |
| Morgan Stanley | 325,811 | $24.3M | 0.0% | +52,058 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Ingevity Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARIngevity Corp1
- CIK0001653477
- Employer ID (EIN)47-40277645
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsDecember 311
- Industry code (SIC)2800 Chemicals & Allied Products1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address4920 O'Hear Avenue, Suite 400, North Charleston, SC 294051
- Phone84374023001
- Shares outstanding34,377,922 as of Jul 24, 202612
- Public float$1.6B as of Jun 30, 20255
- AuditorPricewaterhouseCoopers LLP, Charlotte, North Carolina PCAOB ID 238; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceOct 6, 20151
- Filings658 in all: 4 (315), 8-K (115), 3 (36), 10-Q (32), SC 13G/A (25), DEFA14A (17), 4/A (16), UPLOAD (12)1
All 33 form types
10-K (10), CORRESP (10), DEF 14A (9), 10-12B/A (7), SC 13G (7), 144 (6), S-8 (5), ARS (4), SCHEDULE 13G/A (4), 5 (3), DFAN14A (3), SC 13D/A (3), 8-K/A (2), DEFC14A (2), PRE 14A (2), PREC14A (2), SCHEDULE 13G (2), SEC STAFF LETTER (2), 10-12B (1), CERTNYS (1), DEFR14A (1), PRER14A (1), PRRN14A (1), S-8 POS (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Feb 26, 2026
Quarterly report (10-Q) Jul 30, 2026
Proxy statement (DEF 14A) Mar 17, 2026
Latest 8-K (8-K) Jul 29, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock ($0.01 par value) | NGVT | New York Stock Exchange |
From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks Ingevity Corp names in Item 1A of its 10-K filed Feb 26, 2026: 25 risks under these headings, as written.5
- If any of the following risks and uncertainties develop into actual events, these events could have a material adverse effect on our business, financial condition. or results of operations. In such case, the trading price of our Common Stock could decline.
- Operational Risks
- Our review of strategic alternatives for the APT reportable segment and Performance Chemicals road markings product line may not result in a transaction and any transaction we enter into, including the completed sale of our North Charleston CTO refinery assets and the majority of the Performance Chemicals industrial specialties product line, may not yield the expected results or benefits.
- We are dependent upon third parties for the provision of certain critical operating services at several of our plants.
- Disruptions at any of our plants could negatively impact our production, financial condition and results of operations.
- Supply Chain Risks
- We purchase a variety of raw materials, which are subject to pricing pressures and limited availability; inability to procure these raw materials or to pass on price increases could negatively impact our operations or financial results.
- Disruptions within our supply chain could negatively impact, our production, financial condition and results of operations.
- International Operations Risks
- We are exposed to the risks inherent in international sales and operations.
- Changes in tariff regimes could negatively impact our business.
- Market Risks
The other 17 risks
- Adverse conditions in the automotive market may negatively impact demand for our automotive carbon products.
- The Company's pavement technologies product line is heavily dependent on government infrastructure spending.
- We face competition from new technologies and new or emerging competitors.
- Certain of our products face competition from substitute products where the costs of different raw material inputs can impact the price competitiveness of our products and negatively impact our sales and/or profits as we respond to substitute product competition.
- Certain of the Company's products are sold into cyclical end-markets, such as the automotive market and the apparel market, which are impacted by changes in consumer and industrial demand.
- We are dependent on certain large customers.
- We are dependent on attracting and retaining key personnel.
- The inability to make or effectively integrate future acquisitions may negatively affect our results.
- As we rely on information technologies to conduct our business, cyber-attacks, data and privacy breaches, or a failure of information technology systems could disrupt our operations and expose us to liability, which could cause our business and reputation to suffer.
- Legal and Regulatory Risks
- From time to time, we may be engaged in legal actions associated with our intellectual property rights; if we are unsuccessful, these could potentially result in an adverse effect on our financial condition and results of operations.
- Environmental and Sustainability Risks
- Certain elements of our strategic growth are dependent on the adoption of more stringent air quality standards around the world.
- Our business involves hazards associated with chemical manufacturing, storage, transportation and disposal; the legal and regulatory environment related to such chemicals could require expenditures or changes to our product formulations and operations.
- Our operations are subject to a wide range of general and industry-specific environmental laws and regulations; changes to this legal and regulatory landscape could limit our business activities and increase our operating costs.
- Adverse weather conditions and other environmental impacts (such as climate change and extreme weather) may impact our operations and the demand for some of our products, which could negatively affect our financial condition and results of operations.
- Financial and Economic Risks
- We may be adversely affected by general global economic and financial conditions beyond our control.
- Inflation could result in an adverse impact on our results of operations.
- Challenges in the commercial and credit environment may materially adversely affect Ingevity's future access to capital.
Legal proceedings
Information regarding certain of these matters is set forth in Note 17 – Commitments and Contingencies to the Consolidated Financial Statements included within Part II. Item 8 of this Form 10-K.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIngevity Corp filings on SEC EDGAR
- 2
- 3SEC EDGARIngevity Corp filings on SEC EDGAR
- 4
- 5
- 6SEC EDGARIngevity Corp 10-K for fiscal 2025
- 7SEC EDGARIngevity Corp 10-K for fiscal 2019
- 8SEC EDGARIngevity Corp 10-K for fiscal 2020
- 9SEC EDGARIngevity Corp 10-K for fiscal 2021
- 10SEC EDGARIngevity Corp 10-K for fiscal 2022
- 11SEC EDGARIngevity Corp 10-Q for fiscal 2026
- 12SEC EDGARIngevity Corp 10-Q for fiscal 2026
- 13SEC EDGARIngevity Corp 10-K for fiscal 2019
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARMichael N. Shukov, SVP and Pres, APT
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32SEC EDGARFrancis David Segal, Board member
- 33SEC EDGARJ. Kevin Willis, Board member
- 34SEC EDGARBruce D. Hoechner, Board member
- 35SEC EDGARBenjamin G. Wright, Board member
- 36SEC EDGARWilliam J. Slocum, Board member
- 37SEC EDGARDiane H. Gulyas, Board member
- 38SEC EDGARKaren G. Narwold, Board member
- 39SEC EDGARSteven C. Voorhees, Board member
- 40SEC EDGARWard H. Dickson, Board member
- 41SEC EDGARJean S. Blackwell, Board member
- 42SEC EDGARDaniel F. Sansone, Board member
- 43SEC EDGARFrederick J. Lynch, Board member
- 44SEC EDGARJ. Michael Fitzpatrick, Board member
- 45SEC EDGARLuis M. Fernandez, Board member
- 46SEC EDGARRichard B. Kelson, Board member
- 47
- 48SEC EDGARResults of operations
- 49SEC EDGARExecutive or director change
- 50SEC EDGARResults of operations
- 51
- 52SEC EDGARRegulation FD disclosure
- 53
- 54
- 55SEC EDGARExecutive or director change
- 56
- 57SEC EDGARRegulation FD disclosure
- 58
- 59SEC EDGARRegulation FD disclosure
- 60NasdaqNasdaq calendar
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73